GENOR (06998) saw its shares rise more than 9% before the midday break. As of the latest update, the stock was up 8.68%, trading at HK$2.88, with a turnover of HK$6.9259 million. On December 30, Eton Pharmaceuticals completed a reverse takeover, finalizing a share swap and listing merger with GENOR. The completion of this reverse takeover marks the official establishment of GENOR and signifies a new phase of strategic integration and development. The Chinese stock abbreviation for GENOR-B has been changed from "嘉和生物" to "亿腾嘉和," effective from 9:00 AM on February 6, 2026. It is noteworthy that GENOR announced last month its intention to repurchase company shares from the open market from time to time. The company has conducted share buybacks for multiple consecutive days since January 28. As of February 5, the cumulative repurchase amount reached approximately HK$18.517 million, involving a total of 7.245 million shares.